Cargando…

Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors

Giant cell arteritis and Takayasu arteritis are two types of primary large-vessel vasculitis (LVV). Although glucocorticoids (GC) are the standard treatment for LVV, the disease relapse rates are high. Recent clinical trials on biological disease-modifying anti-rheumatic drugs (bDMARDs) and Janus ki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Kotaro, Suzuki, Katsuya, Takeshita, Masaru, Takeuchi, Tsutomu, Kaneko, Yuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183585/ https://www.ncbi.nlm.nih.gov/pubmed/37197652 http://dx.doi.org/10.3389/fimmu.2023.1197342

Ejemplares similares

Interleukin‐1 pathway in active large vessel vasculitis patients with a poor prognosis: a longitudinal transcriptome analysis
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
por: Matsumoto, Kotaro, et al.
Publicado: (2019)

Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease
por: Akiyama, Mitsuhiro, et al.
Publicado: (2021)

Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses
por: Matsumoto, Kotaro, et al.
Publicado: (2021)

Vasculitogenic T Cells in Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022)

Janus Kinase Inhibitors and Cell Therapy
por: Assal, Amer, et al.
Publicado: (2021)

Perspectives of JAK Inhibitors for Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022)

Janus kinase inhibitors in autoimmune bullous diseases
por: Huang, Dawei, et al.
Publicado: (2023)

Longitudinal immune cell monitoring identified CD14(++) CD16(+) intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis
por: Matsumoto, Kotaro, et al.
Publicado: (2020)

Cellular Signaling Pathways in Medium and Large Vessel Vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2020)

Pathogenic role of monocytes/macrophages in large vessel vasculitis
por: Watanabe, Ryu, et al.
Publicado: (2022)

Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies
por: Hammitzsch, Ariane, et al.
Publicado: (2020)

Targeting the Janus Kinase Family in Autoimmune Skin Diseases
por: Howell, Michael D., et al.
Publicado: (2019)

Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
por: Qi, Fei, et al.
Publicado: (2021)

Tendonitis on the Fingers in Behçet's Disease
por: Matsumoto, Kotaro, et al.
Publicado: (2018)

Molecular dissection of Janus kinases as drug targets for inflammatory diseases
por: Kwon, Sunghark
Publicado: (2022)

Distinct gene signatures of monocytes and B cells in patients with giant cell arteritis: a longitudinal transcriptome analysis
por: Matsumoto, Kotaro, et al.
Publicado: (2023)

Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System
por: Kubo, Satoshi, et al.
Publicado: (2018)

Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel vasculitis: A preliminary observational study
por: Abe, Nobuya, et al.
Publicado: (2022)

IgG4-Related Disease: A Growing Appreciation of Follicular Helper T Cell Expansion
por: Akiyama, Mitsuhiro, et al.
Publicado: (2019)

Streptococcal Enzymes as Precision Tools Against Pathogenic IgG Autoantibodies in Small Vessel Vasculitis
por: Segelmark, Mårten, et al.
Publicado: (2019)

Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment
por: Saito, Shuntaro, et al.
Publicado: (2018)

Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
por: Quadri, Iman, et al.
Publicado: (2023)

Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
por: Takeshita, Masaru, et al.
Publicado: (2022)

A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis
por: Saito, Shuntaro, et al.
Publicado: (2017)

Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer
por: Daza-Cajigal, Vanessa, et al.
Publicado: (2019)

Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions
por: Fetter, Tanja, et al.
Publicado: (2020)

Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs
por: Hanaoka, Hironari, et al.
Publicado: (2022)

An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome
por: Sic, Heiko, et al.
Publicado: (2017)

Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway
por: Dang, Chun, et al.
Publicado: (2021)

Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria
por: Daza-Cajigal, Vanessa, et al.
Publicado: (2022)

Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis
por: Albeituni, Sabrin, et al.
Publicado: (2023)

Small vessel vasculitis
por: Brogan, Paul, et al.
Publicado: (2009)

Large vessel vasculitis
por: Gulati, Ashima, et al.
Publicado: (2009)

Comparison of the Clinical Characteristics of Pneumocystis Pneumonia between Patients with Rheumatoid Arthritis Being Treated with Biologics and Those Being Treated without Biologics
por: Akiyama, Mitsuhiro, et al.
Publicado: (2017)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism
por: Nan, Yuchen, et al.
Publicado: (2017)

Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
por: Li, Wendao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5267img7lbb2ag9tsllkocnqj